Bavarian Nordic raises 2022 annual guidance again after monkeypox vaccine deals
(Reuters) – Danish biotechnology company Bavarian Nordic revised its annual guidance on Monday for a second time after signing supply contracts with several undisclosed countries for its Imvanex monkeypox vaccine. Bavarian Nordic said vaccine deliveries would start immediately and added that it was in discussions with more countries regarding vaccine supply. “We are pleased to …
Bavarian Nordic raises 2022 annual guidance again after monkeypox vaccine deals Read More »









